Annual Working Capital
$90.57 M
-$54.89 M-37.73%
31 December 2023
Summary:
Cara Therapeutics annual working capital is currently $90.57 million, with the most recent change of -$54.89 million (-37.73%) on 31 December 2023. During the last 3 years, it has fallen by -$86.02 million (-48.71%). CARA annual working capital is now -48.71% below its all-time high of $176.58 million, reached on 31 December 2020.CARA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$37.87 M
-$12.09 M-24.19%
30 September 2024
Summary:
Cara Therapeutics quarterly working capital is currently $37.87 million, with the most recent change of -$12.09 million (-24.19%) on 30 September 2024. Over the past year, it has dropped by -$39.85 million (-51.27%). CARA quarterly working capital is now -78.55% below its all-time high of $176.58 million, reached on 31 December 2020.CARA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.7% | -51.3% |
| 3 y3 years | -48.7% | -75.7% |
| 5 y5 years | -29.1% | -75.6% |
CARA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.7% | at low | -76.1% | at low |
| 5 y | 5 years | -48.7% | at low | -78.5% | at low |
| alltime | all time | -48.7% | >+9999.0% | -78.5% | +8369.2% |
Cara Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $37.87 M(-24.2%) |
| June 2024 | - | $49.96 M(-24.5%) |
| Mar 2024 | - | $66.13 M(-27.0%) |
| Dec 2023 | $90.57 M(-37.7%) | $90.57 M(+16.5%) |
| Sept 2023 | - | $77.72 M(-21.7%) |
| June 2023 | - | $99.28 M(-21.2%) |
| Mar 2023 | - | $125.98 M(-13.4%) |
| Dec 2022 | $145.45 M(-6.6%) | $145.45 M(-8.3%) |
| Sept 2022 | - | $158.59 M(+2.3%) |
| June 2022 | - | $155.00 M(+16.1%) |
| Mar 2022 | - | $133.47 M(-14.3%) |
| Dec 2021 | $155.67 M(-11.8%) | $155.67 M(-0.2%) |
| Sept 2021 | - | $155.97 M(+4.5%) |
| June 2021 | - | $149.30 M(-13.1%) |
| Mar 2021 | - | $171.83 M(-2.7%) |
| Dec 2020 | $176.58 M(+43.8%) | $176.58 M(+51.9%) |
| Sept 2020 | - | $116.24 M(-0.8%) |
| June 2020 | - | $117.19 M(+17.1%) |
| Mar 2020 | - | $100.07 M(-18.5%) |
| Dec 2019 | $122.76 M(-3.9%) | $122.76 M(-20.9%) |
| Sept 2019 | - | $155.16 M(+83.4%) |
| June 2019 | - | $84.61 M(-16.8%) |
| Mar 2019 | - | $101.75 M(-20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $127.69 M(+47.5%) | $127.69 M(-24.1%) |
| Sept 2018 | - | $168.14 M(+62.1%) |
| June 2018 | - | $103.70 M(+44.2%) |
| Mar 2018 | - | $71.94 M(-16.9%) |
| Dec 2017 | $86.55 M(+73.4%) | $86.55 M(-12.3%) |
| Sept 2017 | - | $98.70 M(-9.1%) |
| June 2017 | - | $108.61 M(+280.9%) |
| Mar 2017 | - | $28.52 M(-42.9%) |
| Dec 2016 | $49.91 M(-51.9%) | $49.91 M(-28.9%) |
| Sept 2016 | - | $70.19 M(-13.3%) |
| June 2016 | - | $80.97 M(-13.3%) |
| Mar 2016 | - | $93.39 M(-9.9%) |
| Dec 2015 | $103.67 M(+108.4%) | $103.67 M(-7.7%) |
| Sept 2015 | - | $112.31 M(+175.3%) |
| June 2015 | - | $40.79 M(-10.6%) |
| Mar 2015 | - | $45.63 M(-8.3%) |
| Dec 2014 | $49.75 M(+445.2%) | $49.75 M(-6.7%) |
| Sept 2014 | - | $53.32 M(-10.3%) |
| June 2014 | - | $59.44 M(-4.9%) |
| Mar 2014 | - | $62.47 M(+584.6%) |
| Dec 2013 | $9.13 M(-2092.4%) | $9.13 M(-17.6%) |
| Sept 2013 | - | $11.07 M(-2517.5%) |
| Dec 2012 | -$458.00 K(-128.1%) | -$458.00 K |
| Dec 2011 | $1.63 M | - |
FAQ
- What is Cara Therapeutics annual working capital?
- What is the all time high annual working capital for Cara Therapeutics?
- What is Cara Therapeutics annual working capital year-on-year change?
- What is Cara Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cara Therapeutics?
- What is Cara Therapeutics quarterly working capital year-on-year change?
What is Cara Therapeutics annual working capital?
The current annual working capital of CARA is $90.57 M
What is the all time high annual working capital for Cara Therapeutics?
Cara Therapeutics all-time high annual working capital is $176.58 M
What is Cara Therapeutics annual working capital year-on-year change?
Over the past year, CARA annual working capital has changed by -$54.89 M (-37.73%)
What is Cara Therapeutics quarterly working capital?
The current quarterly working capital of CARA is $37.87 M
What is the all time high quarterly working capital for Cara Therapeutics?
Cara Therapeutics all-time high quarterly working capital is $176.58 M
What is Cara Therapeutics quarterly working capital year-on-year change?
Over the past year, CARA quarterly working capital has changed by -$39.85 M (-51.27%)